Helping patients with a chemotherapy-resistant leukaemia avoid ineffective treatment

    NAME Dr. Daniel Speidel
    CANCER TYPE Leukaemia
    INSTITUTION Children's Medical Research Institute
    STATE New South Wales
    GRANT TYPE Other
    PROJECT TYPE Support

    "We aim to validate a new diagnostic test that can fast-track patients with chemotherapy-resistant leukaemia towards alternative therapies. This will accelerate treatment, reduce suffering and increase the chance of a cure."

    Daniel Speidel, Children's Medical Research Institute